Open AccessA Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Author(s) -
Paul C. McDonald,
Stephen Chia,
Philippe L. Bedard,
Quincy Chu,
Michael P. A. Lyle,
Lisa Tang,
Madhu Singh,
Zaihui Zhang,
Claudiu T. Supuran,
Daniel J. Renouf,
Shoukat Dedhar
Publication year - 2020
Publication title -
american journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.896
H-Index - 78
eISSN - 1537-453X
pISSN - 0277-3732
DOI - 10.1097/coc.0000000000000691
Subject(s) - medicine , tolerability , cmax , discontinuation , pharmacokinetics , nausea , adverse effect , dosing , cohort , vomiting , gastroenterology , response evaluation criteria in solid tumors , pharmacology , phases of clinical research , toxicity